News NICE backs Alimera’s three-year uveitis implant An implant developed by Alimera Sciences has been recommended by NICE to treat an inflammatory eye disease that can cau
News Vaccines mistrust a “global crisis” says Wellcome report A wide-ranging survey involving 140,000 people in 140 countries has revealed a worryingly high level of concern about the safety of vaccines, with scepticism highest in the developed world.
News Merck claims a brace of head and neck cancer approvals Merck & Co/MSD has done the double in head and neck cancer with a pair of FDA approvals for Keytruda in newly diagnosed patients on the same day.
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
